A Double-Blind, Vehicle Controlled, Randomized, Phase II Study of SR-T100 Gel on External Genital Warts/Condyloma Acuminate (EGWs)
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2018
At a glance
- Drugs SR T100 (Primary)
- Indications Condylomata acuminata
- Focus Therapeutic Use
- Sponsors G&E Herbal Biotechnology
- 03 Dec 2018 Status changed from active, no longer recruiting to completed.
- 31 Jul 2018 Planned primary completion date changed from 1 May 2018 to 1 Sep 2018.
- 13 Feb 2018 Planned End Date changed from 1 Apr 2018 to 1 Dec 2018.